Detalles de la búsqueda
1.
Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial.
Int J Cancer
; 153(8): 1520-1528, 2023 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37391938
2.
Intensity-modulated radiotherapy and cisplatin-based chemotherapy for anal cancer: long-term outcomes at a single institution.
Int J Colorectal Dis
; 38(1): 123, 2023 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37162567
3.
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis.
Oncologist
; 25(6): e928-e935, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31943506
4.
Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy.
Int J Colorectal Dis
; 35(4): 685-694, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32036405
5.
Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC.
Future Oncol
; 14(14): 1339-1346, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846100
6.
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial.
Br J Cancer
; 117(8): 1099-1104, 2017 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28926529
7.
Cost effectiveness of different central venous approaches for port placement and use in adult oncology patients: evidence from a randomized three-arm trial.
Ann Surg Oncol
; 21(12): 3725-31, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24841352
8.
The role of anti-EGFR rechallenge in metastatic colorectal cancer, from available data to future developments: A systematic review.
Cancer Treat Rev
; 124: 102683, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38237253
9.
Immunotherapy in the neoadjuvant treatment of gastrointestinal tumors: is the time ripe?
J Immunother Cancer
; 12(5)2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38782539
10.
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled Trial.
JAMA Netw Open
; 7(4): e245635, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38592721
11.
Factors predicting worse prognosis in patients affected by pT3 N0 colon cancer: long-term results of a monocentric series of 137 radically resected patients in a 5-year period.
Int J Colorectal Dis
; 28(2): 207-15, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22903336
12.
Tumour-specific mesorectal excision for rectal cancer: Systematic review and meta-analysis of oncological and functional outcomes.
Eur J Surg Oncol
; 49(11): 107069, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37708660
13.
Observational Study on Antibody Response to COVID-19 Vaccines in PAtients with Gastro-Entero-PanCreatic Cancers and NeuroendocrIne NeoplAsms on Systemic TreatmEnts (VACCINATE).
Biomedicines
; 11(2)2023 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36830873
14.
Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials.
Cancers (Basel)
; 15(7)2023 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046778
15.
Immune-checkpoint inhibitors in anal squamous cell carcinoma: a systematic review and meta-analysis.
Semin Oncol
; 50(6): 140-143, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38065801
16.
Vitamin D Supplementation and Adherence to World Cancer Research Fund (WCRF) Diet Recommendations for Colorectal Cancer Prevention: A Nested Prospective Cohort Study of a Phase II Randomized Trial.
Biomedicines
; 11(6)2023 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37371861
17.
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 9(7): 966-970, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37200022
18.
PD-1/PD-L1 blockade, a novel strategy for targeting metastatic colorectal cancer: A systematic review and meta-analysis of randomized trials.
Oncol Lett
; 23(4): 134, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35251353
19.
Small-size (40 µm) Beads Loaded with Irinotecan in the Treatment of Patients with Colorectal Liver Metastases.
Cardiovasc Intervent Radiol
; 45(6): 770-779, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35029709
20.
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients.
Neoplasia
; 34: 100842, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36279751